FdaApplication
ANDA 209898
Identifiers
- fda_app_no: ANDA209898
Properties
| Property | Value |
|---|---|
| applicant_name | REGCON HOLDINGS LLC |
| application_type | ANDA |
| approval_date | 2020-09-11 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| APIXABAN | APIXABAN | 5MG | TABLET;ORAL |
| APIXABAN | APIXABAN | 2.5MG | TABLET;ORAL |
2 products